AR051412A1 - Suspensiones farmaceuticas exentas de colorantes y metodods relacionados - Google Patents

Suspensiones farmaceuticas exentas de colorantes y metodods relacionados

Info

Publication number
AR051412A1
AR051412A1 ARP050104554A ARP050104554A AR051412A1 AR 051412 A1 AR051412 A1 AR 051412A1 AR P050104554 A ARP050104554 A AR P050104554A AR P050104554 A ARP050104554 A AR P050104554A AR 051412 A1 AR051412 A1 AR 051412A1
Authority
AR
Argentina
Prior art keywords
effective amount
related methods
exempted
colors
pharmaceutical suspensions
Prior art date
Application number
ARP050104554A
Other languages
English (en)
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of AR051412A1 publication Critical patent/AR051412A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una suspension farmacéutica exenta de colorantes que posee una cantidad terapéuticamente efectiva de un primer agente activo que comprende esencialmente un primer agente activo sustancialmente insoluble en agua, una cantidad efectiva de un edulcorante no reductor; una cantidad efectiva de agua; y una cantidad efectiva de un sistema de suspension; y una cantidad efectiva de un opacante, en donde la suspension farmacéutica exenta de colorantes posee un pH de desde aproximadamente 5 hasta aproximadamente 6 y se encuentra sustancialmente exenta de azucar de reduccion, y métodos relacionados.
ARP050104554A 2004-10-29 2005-10-31 Suspensiones farmaceuticas exentas de colorantes y metodods relacionados AR051412A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/977,670 US20060093630A1 (en) 2004-10-29 2004-10-29 Dye-free pharmaceutical suspensions and related methods

Publications (1)

Publication Number Publication Date
AR051412A1 true AR051412A1 (es) 2007-01-10

Family

ID=35711742

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104554A AR051412A1 (es) 2004-10-29 2005-10-31 Suspensiones farmaceuticas exentas de colorantes y metodods relacionados

Country Status (3)

Country Link
US (1) US20060093630A1 (es)
AR (1) AR051412A1 (es)
WO (1) WO2006050301A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100493503C (zh) * 2006-10-24 2009-06-03 浙江康德药业集团有限公司 一种遮味型小儿感冒干混悬剂及制备方法
UA102254C2 (ru) * 2008-04-25 2013-06-25 Апотекс Технолоджис Инк. Жидкий состав для деферипрона с приятным вкусом
CN102712591B (zh) 2009-07-03 2014-06-25 阿普泰克斯科技公司 3-羟基吡啶-4-酮的氟化衍生物
KR20200053746A (ko) 2018-11-09 2020-05-19 (주)아모레퍼시픽 졸-겔 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485719A (en) * 1967-10-13 1969-12-23 Us Agriculture Continuous process for producing xanthomonas heteropolysaccharide
HU169986B (es) * 1972-12-07 1977-03-28
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
GB8317696D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Preparing xanthomonas heteroplysaccharide
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
IT1286496B1 (it) * 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US6190645B1 (en) * 1999-07-15 2001-02-20 Playtex Products, Inc. Sunscreen for the scalp hair and hair
US6074630A (en) * 1999-11-23 2000-06-13 Devillez; Richard L. Delivery system for suncare products
US7108860B2 (en) * 2002-06-06 2006-09-19 Playtex Products, Inc. Sunscreen compositions
US7285262B2 (en) * 2003-07-11 2007-10-23 Tanning Research Laboratories, Inc. Natural sunlight photostable composition
US7309481B2 (en) * 2005-02-07 2007-12-18 Tanning Research Laboratories, Inc. Natural sunlight photostable composition

Also Published As

Publication number Publication date
US20060093630A1 (en) 2006-05-04
WO2006050301A3 (en) 2007-02-08
WO2006050301A2 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
AR051411A1 (es) Suspensiones farmaceuticas exentas de colorantes y metodos relacionados
AR051944A1 (es) Suspensiones farmaceuticas exentas de colorantes y metodos relacionados
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
DE60312333D1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
ATE485835T1 (de) Antikörper enthaltende pharmazeutische lösungen
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
FI20011851A (fi) Fluoksetiinia tai sen happoadditiosuolaa sisältävä dispergoituva tabletti
ECSP034455A (es) Forma de dosificacion de farmaco activada por hidrogel
YU49202A (sh) Benzazolski derivati i njihova upotreba kao modulatora jnk
DK1151004T3 (da) Fremgangsmåde til fremstilling af IL-1RA, et terapeutisk protein, ud fra legemsvæsker
IS5577A (is) Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar
MY140676A (en) Structured body wash
AR051412A1 (es) Suspensiones farmaceuticas exentas de colorantes y metodods relacionados
NO20022201L (no) Lösninger inneholdende Epinastin
WO2003000203A3 (en) Chlorotoxin inhibition of cell invasion, cancer metastasis, angiogenesis and tissue remodeling
CY1112917T1 (el) Υγρες στοματικες συνθεσεις
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance
GT200200015A (es) Formulacion agroquimica
EA200702496A1 (ru) Местная композиция, содержащая желатин
MA27850A1 (fr) Preparations pharmaceutiques contenant de l'amoxicilline et du clavulanate
PE20130180A1 (es) Soluciones farmaceuticas orales que comprenden telbivudina
AU5487101A (en) Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition
FR2846327B1 (fr) Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
HUP0202744A2 (hu) Orális, rivasztigmint tartalmazó szabályozott hatóanyag-leadású készítmények
WO2002029099A1 (fr) Technique de criblage de substance physiologiquement active

Legal Events

Date Code Title Description
FB Suspension of granting procedure